Neurología

El grupo de Neurología cuenta con una Unidad/Laboratorio de Epilepsia centrada en el estudio de las epilepsias genéticas raras desde el punto de vista clínico y genético, en la caracterización del fenotipo de varios modelos de ratón con la enfermedad de Lafora y en el desarrollo de nuevas terapias. Hasta ahora, ha participado en el descubrimiento de varios genes responsables de varias epilepsias genéticas (destacando el descubrimiento del primer gen de la enfermedad de Lafora). Su reto es desarrollar terapias personalizadas dirigidas a defectos genéticos específicos en las epilepsias. En este último año han iniciado una línea dirigida a desarrollar una terapia génica para la enfermedad de Lafora habiendo registrado la solicitud de patente para un vector viral adenoasociado. También cuenta con una Unidad de Patología Cortical focalizada en el estudio global de las demencias degenerativas familiares, investigando nuevas causas genéticas, analizando biomarcadores diagnósticos en LCR y plasma, y planteando consejo genético.

Contribuciones a la sociedad

La Unidad/Laboratorio de Epilepsia participa en numerosos ensayos clínicos que tienen como objetivo mejorar e implementar los nuevos tratamientos para la epilepsia. Por otro lado, trabaja en la inclusión de pacientes en varios registros como Lafora Disease Registry (LD-Registry), Lennox-Gastaut Registry (LG-Registry), KCNA2-Registry, SLK-Registry y el Registro de Epilepsia Farmacorresistente. Estos registros prospectivos pretenden mejorar el conocimiento de las enfermedades e identificar pacientes candidatos para incluir en futuros ensayos clínicos. También imparten cursos formativos en la Sociedad Española de Neurología (SEN) y en la Sociedad Española de Epilepsia (SEEP).

La Unidad de Patología Cortical participa en actividades docentes y guías de la Sociedad Española de Neurología, y divulgativas de la Asociación de Demencia Frontotemporal.

Colaboraciones

El grupo de Neurología colabora con distintos grupos a nivel nacional e internacional. El Instituto de Biomedicina de Valencia, CSIC, CIBERER (Pascual Sanz); Universidad de Valencia, CIBERER-UV-INCLIVA (Carlos Romá-Mateo); Unitat de Vectors Virals, Universidad Autónoma de Barcelona (Miguel Chillón); Fundación Reina Sofía, Instituto de Neurociencias de Alicante; Amyloid Biomarker Study group, European Early-Onset Dementia Consortium, Secugen S. L.; University of Kentucky, USA (Matthew Gentry).

Tesis doctorales

Relación de publicaciones ordenadas por fecha de publicación

TRIM25 mutation (p.C168*), coding for an E3 ubiquitin ligase, is a cause of early-onset autosomal dominant dementia with amyloid load and parkinsonism.

Gómez-Tortosa E, Baradaran-Heravi Y, Dillen L, Choudhury NR, Agüero Rabes P, Pérez-Pérez J, Kocoglu C, Sainz MJ, Ruiz González A, Téllez R, Cremades-Jimeno L, Cárdaba B, EU EOD Consortium, Van Broeckhoven C, Michlewski G, van der Zee J.

Alzheimers Dement. 2022 Dec 28.

PMID: 36576960

FI: 16,655

Adaptation and Validation of the Spanish Version of Decisional Conflict Scale in People with Migraine in Spain.

Guerrero-Peral ÁL, Porta-Etessam J, Rodríguez-Vico J, Núñez M, Ciudad A, Díaz-Cerezo S, Garí-Peris C, Pérez-Sádaba FJ, Lizán L, Santos-Lasaosa S.

Patient Prefer Adherence. 2022.16:3291-3302.

PMID: 36545540

FI: 2,314

Dual therapy with Erenumab and onabotulinumtoxinA: No synergistic effect in chronic migraine: A retrospective cohort study.

Jaimes A, Gómez A, Pajares O, Rodríguez-Vico J.

Pain Pract. 2022 Dec 12.

PMID: 36507609

FI: 3,079

Meningoencephalitis due to Mycobacterium lentiflavum in an immunocompromised patient: Case report.

Martinez-Poles J, Saldaña-Díaz AI, Esteban J, Lara-Almunia M, Vizarreta Figueroa AT, Martín-Gil L, Cebrián-Escudero J, Fernández-Ferro J.

Eur J Neurol. 2022 Dec 08.

PMID: 36478338

FI: 6,288

Clinical description, molecular delineation and genotype-phenotype correlation in 340 patients with KBG syndrome: addition of 67 new patients.

Martinez-Cayuelas E, Blanco-Kelly F, Lopez-Grondona F, Swafiri ST, Lopez-Rodriguez R, Losada-Del Pozo R, Mahillo-Fernandez I, Moreno B, Rodrigo-Moreno M, Casas-Alba D, Lopez-Gonzalez A, García-Miñaúr S, Ángeles Mori M, Pacio-Minguez M, Rikeros-Orozco E, Santos-Simarro F, Cruz-Rojo J, Quesada-Espinosa JF, Sanchez-Calvin MT, Sanchez-Del Pozo J, Bernado Fonz R, Isidoro-Garcia M, Ruiz-Ayucar I, Alvarez-Mora MI, Blanco-Lago R, De Azua B, Eiris J, Garcia-Peñas JJ, Gil-Fournier B, Gomez-Lado C, Irazabal N, Lopez-Gonzalez V, Madrigal I, Malaga I, Martinez-Menendez B, Ramiro-Leon S, Garcia-Hoyos M, Prieto-Matos P, Lopez-Pison J, Aguilera-Albesa S, Alvarez S, Fernández-Jaén A, Llano-Rivas I, Gener-Querol B, Ayuso C, Arteche-Lopez A, Palomares-Bralo M, Cueto-González A, Valenzuela I, Martinez-Monseny A, Lorda-Sanchez I, Almoguera B.

J Med Genet. 2022 Nov 29.

PMID: 36446582

FI: 5,945

The spectrum of epilepsy with eyelid myoclonia: delineation of disease subtypes from a large multicenter study.

Cerulli Irelli E, Cocchi E, Ramantani G, Riva A, Caraballo RH, Morano A, Giuliano L, Yilmaz T, Panagiotakaki E, Operto FF, Giraldez BG, Balestrini S, Silvennoinen K, Casciato S, Comajuan M, Fortunato F, Giallonardo AT, Gamirova R, Coppola A, Di Gennaro G, Labate A, Sofia V, Kluger GJ, Gambardella A, Kasteleijn-Nolst Trenite D, Baykan B, Sisodiya SM, Arzimanoglou A, Striano P, Di Bonaventura C; EMA study group..

Epilepsia. 2022 Oct 28.

PMID: 36307934

FI: 6,74

Early Treatment with Metformin Improves Neurological Outcomes in Lafora Disease.

Burgos DF, Machío-Castello M, Iglesias-Cabeza N, Giráldez BG, González-Fernández J, Sánchez-Martín G, Sánchez MP, Serratosa JM.

Neurotherapeutics. 2022 Oct 27.

PMID: 36303102

FI: 6,088

Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events: One-Year Follow-up.

Nguyen TN, Qureshi MM, Klein P, et.al.

Neurology. 2022 Oct 18.

PMID: 36257718

FI: 12,258

Path Analysis Models Integrating Psychological, Psycho-physical and Clinical Variables in Individuals With Tension-Type Headache.

Liew BXW, Palacios-Ceña M, Scutari M, Fuensalida-Novo S, Guerrero-Peral A, Ordás-Bandera C, Pareja JA, Fernández-de-Las-Peñas C.

J Pain. 2022 Oct 13.

PMID: 36244659

FI: 5,383

Network Analysis Reveals That Headache-Related, Psychological and Psycho-Physical Outcomes Represent Different Aspects in Women with Migraine.

Fernández-de-Las-Peñas C, Florencio LL, Varol U, Pareja JA, Ordás-Bandera C, Valera-Calero JA.

Diagnostics (Basel). 2022 Sep 26.12(10).

PMID: 36292007

FI: 3,992

Neutrophil β1 adrenoceptor blockade blunts stroke-associated neuroinflammation.

Clemente-Moragón A, Oliver E, Calle D, Cussó L, Gómez M, Pradillo JM, Castejón R, Rallón N, Benito JM, Fernández-Ferro JC, Carneado-Ruíz J, Moro MA, Sánchez-González J, Fuster V, Cortés-Canteli M, Desco M, Ibáñez B.

Br J Pharmacol. 2022 Sep 30.

PMID: 36181002

FI: 9,473

Functional neurological symptoms as initial presentation of Creutzfeldt-Jakob disease: case series.

Gómez-Mayordomo V, Kojovi? M, López-Valdés E, Alonso-Frech F, Horga A, Fernández-Rodríguez R, Pareés I.

J Neurol. 2022 Sep 30.

PMID: 36175672

FI: 6,682

Headache: what to ask, how to examine, and what scales to use. Recommendations of the Spanish society of neurology's headache study group.

Gago-Veiga AB, Camiña Muñiz J, García-Azorín D, González-Quintanilla V, Ordás CM, Torres-Ferrus M, Santos-Lasaosa S, Viguera-Romero J, Pozo-Rosich P.

Neurologia (Engl Ed). 2022 Sep.37(7):564-574.

PMID: 36064285

FI: 5,486

Polypill Strategy in Secondary Cardiovascular Prevention.

Castellano JM, Pocock SJ, Bhatt DL, Quesada AJ, Owen R, Fernandez-Ortiz A, Sanchez PL, Marin Ortuño F, Vazquez Rodriguez JM, Domingo-Fernández A, Lozano I, Roncaglioni MC, Baviera M, Foresta A, Ojeda-Fernandez L, Colivicchi F, Di Fusco SA, Doehner W, Meyer A, Schiele F, Ecarnot F, Linhart A, Lubanda JC, Barczi G, Merkely B, Ponikowski P, Kasprzak M, Fernandez Alvira JM, Andres V, Bueno H, Collier T, Van de Werf F, Perel P, Rodriguez-Manero M, Alonso Garcia A, Proietti M, Schoos MM, Simon T, Fernandez Ferro J, Lopez N, Beghi E, Bejot Y, Vivas D, Cordero A, Ibañez B, Fuster V, SECURE Investigators.

N Engl J Med. 2022 09 15.387(11):967-977.

PMID: 36018037

FI: 176,082

Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice.

Alonso-Singer P, Aguilar-Amat Prior MJ, Oliva-Navarro J, Massot-Tarrús A, Giráldez BG, Bermejo P, DeToledo-Heras M, Aledo-Serrano Á, Martínez-Cayuelas E, Tirado-Requero P, Velázquez-Fragua R, López-Sobrino G, Ojeda J.

Epilepsy Behav. 2022 Sep.134:108836.

PMID: 35870432

FI: 3,337

Smell and Taste Dysfunction in Pediatric Patients With SARS-CoV-2 Infection.

Púa Torrejón RC, Ordoño Saiz MV, González Alguacil E, Furones García M, Cantarín Extremera V, Ruiz Falcó ML, Soto Insuga V.

Pediatr Neurol. 2022 Aug 01.136:28-33.

PMID: 36084419

FI: 4,21

Hemihypomimia in Parkinson's disease: an under-recognized clinical sign?

Guerra-Hiraldo JD, López-Jiménez A, Gasca-Salas C, Maycas-Cepeda T, Gómez-Sanchez P, López-Manzanares L, Mata Guerra-Hiraldo M, Prieto-Jurczynska C, Eimil M, Vela-Desojo L, Pareés I, Jiménez-Huete A, Kurtis MM.

J Neurol. 2022 Aug 04.

PMID: 35925399

FI: 6,682

Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain.

Ángel Calleja M, Navarro A, Serratosa JM, Toledo M, Villanueva V, Subías Labazuy S, Gil A.

Expert Rev Pharmacoecon Outcomes Res. 2022 Aug 03:1-10.

PMID: 35904256

FI: 2,039

Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease.

Quinn L, Playle R, Drew CJG, Taiyari K, Williams-Thomas R, Muratori LM, Hamana K, Griffin BA, Kelson M, Schubert R, Friel C, Morgan-Jones P, Rosser A, Busse M, PACE-HD site investigators (Montojo T).

Parkinsonism Relat Disord. 2022 Aug.101:75-89.

PMID: 35809488

FI: 4,402

Generalized dystonia without Parkinsonism in an LRRK2 carrier.

Díaz-Feliz L, Feliz-Feliz C, Del Val J, Ávila-Fernández A, Lorda-Sanchez I, García-Ruiz PJ.

Clin Park Relat Disord. 2022.7:100157.

PMID: 35941989

FI: 0

On Disease Modifying and Neuroprotective Treatments for Parkinson's Disease: Physical Exercise.

Garcia Ruiz PJ, Luquin Piudo R, Martinez Castrillo JC.

Front Neurol. 2022.13:938686.

PMID: 35911891

FI: 4,086

Author Correction: Regulatory rare variants of the dopaminergic gene ANKK1 as potential risk factors for Parkinson's disease.

Pérez-Santamarina E, García-Ruiz P, Martínez-Rubio D, Ezquerra M, Pla-Navarro I, Puente J, Martí MJ, Palau F, Hoenicka J.

Sci Rep. 2022 Jul 26.12(1):12719.

PMID: 35882974

FI: 4,997

Clinical and structural brain correlates of hypomimia in early-stage Parkinson's disease.

Sampedro F, Martínez-Horta S, Horta-Barba A, Grothe MJ, Labrador-Espinosa MA, Jesús S, Adarmes-Gomez A, Carrillo F, Puig-Davi A, Roldan-Lora F, Aguilar-Barbera M, Pastor P, Arroyo SE, Vila BS, Cots-Foraster A, Ruiz-Martínez J, Carrillo-Padilla F, Pueyo-Morlans M, Gonzalez-Aramburu I, Infante-Ceberio J, Hernandez-Vara J, de Fabregues-Boixar O, de Deus Fonticoba T, Avila A, Martínez-Castrillo JC, Bejr-Kasem H, Campolongo A, Pascual-Sedano B, Martínez-Martín P, Santos-García D, Mir P, COPPADIS Study Group, Garcia-Ruiz PJ, Kulisevsky J.

Eur J Neurol. 2022 Jul 19.

PMID: 35852918

FI: 6,288

Impact of new technologies on neurology in Spain. Review by the New Technologies Ad-Hoc Committee of the Spanish Society of Neurology.

López-Blanco R, Sorrentino Rodriguez A, Cubo E, Gabilondo Í, Ezpeleta D, Labrador-Espinosa MÁ, Sánchez-Ferro Á, Tejero C, Matarazzo M, SEN's New Technologies Ad-Hoc Committee.

Neurologia (Engl Ed). 2022 Jul 13.

PMID: 35842132

FI: 5,486

Diaphragm impairment in patients admitted for severe COVID-19.

López-Viñas L, Vega-Villar J, Rocío-Martín E, García-García P, De La Rosa Santiago E, Galván-Román JM, Wix-Ramos R.

Eur J Transl Myol. 2022 Jun 21.

PMID: 35727218

FI: 0

Machine-learning based approach to predict anti-CGRP response in patients with migraine: multicenter Spanish study.

Gonzalez-Martinez A, Pagán J, Sanz-García A, García-Azorín D, Rodriguez Vico JS, Jaimes A, Gómez García A, Díaz de Terán J, González-García N, Quintas S, Belascoaín R, Casas Limón J, Latorre G, Calle de Miguel C, Sierra Á, Guerrero-Peral ÁL, Trevino-Peinado C, Gago-Veiga AB.

Eur J Neurol. 2022 Jun 20.

PMID: 35726393

FI: 6,288

Onset of efficacy and adverse events during Cenobamate titration period.

Steinhoff BJ, Ben-Menachem E, Brandt C, García Morales I, Rosenfeld WE, Santamarina E, Serratosa JM.

Acta Neurol Scand. 2022 Jun 16.

PMID: 35711112

FI: 3,915

Times to endovascular treatment following two triage models.

Fernandez-Ferro J, Guillan Rodriguez M, Marquez MP, Lopez JE, Carbonero MTC, de Yebenes MJG, Bordallo NB, Sanchez MJG, Perez ER, Fernandez CR.

Neurol Sci. 2022 Jun.43(6):3967-3971.

PMID: 35257258

FI: 3,83

Greater occipital nerve (GON) blocks for treating of hypnic headache: A case report.

Wix Ramos R, Rocio Martín E, Luque Cárdenas C, López Viñas L, Gago Veiga A.

Sleep Med. 2022 May 28.97:10-12.

PMID: 35679776

FI: 4,842

Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality.

Nguyen TN, Qureshi MM, Klein P, et. al.

J Stroke. 2022 05.24(2):256-265.

PMID: 35677980

FI: 8,632

Predictors of the change in burden, strain, mood, and quality of life among caregivers of Parkinson's disease patients.

Santos-García D, de Deus Fonticoba T, Cores Bartolomé C, Íñiguez Alvarado MC, Feal Panceiras MJ, Suárez Castro E, Canfield H, Martínez Miró C, Jesús S, Aguilar M, Pastor P, Planellas L, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Puente V, Dotor García-Soto J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, Ariztegui NL, Gastón I, Kulisevsky J, Blázquez Estrada M, Seijo M, Martínez JR, Valero C, Kurtis M, de Fábregues O, González Ardura J, Alonso Redondo R, Ordás C, López DíazL LM, McAfee D, Martinez-Martin P, Mir P, COPPADIS Study Group.

Int J Geriatr Psychiatry. 2022 May 17.37(6).

PMID: 35633051

FI: 3,85

Motor Fluctuations Development Is Associated with Non-Motor Symptoms Burden Progression in Parkinson's Disease Patients: A 2-Year Follow-Up Study.

Santos-García D, de Deus Fonticoba T, Bartolomé CC, Painceiras MJF, Castro ES, Canfield H, Miró CM, Jesús S, Aguilar M, Pastor P, Planellas L, Cosgaya M, Caldentey JG, Caballol N, Legarda I, Hernández-Vara J, Cabo I, Manzanares LL, Aramburu IG, Rivera MAÁ, Mayordomo VG, Nogueira V, Puente V, García-Soto JD, Borrué C, Vila BS, Sauco MÁ, Vela L, Escalante S, Cubo E, Padilla FC, Castrillo JCM, Alonso PS, Losada MGA, Ariztegui NL, Gastón I, Kulisevsky J, Estrada MB, Seijo M, Martínez JR, Valero C, Kurtis M, de Fábregues O, Ardura JG, Redondo RA, Ordás C, Díaz LML, McAfee D, Martinez-Martin P, Mir P, Coppadis Study Group.

Diagnostics (Basel). 2022 May 05.12(5).

PMID: 35626303

FI: 3,992

Sleep, chronotype, and behavior in adolescents with attention-deficit/hyperactivity disorder.

Martinez-Cayuelas E, Moreno-Vinues B, Pozo RL, Rodrigo-Moreno M, Soto-Insuga V, Pérez-Villena A.

Arch Pediatr. 2022 May.29(4):277-280.

PMID: 35387750

FI: 1,82

Electroclinical Features and Long-term Seizure Outcome in Patients With Eyelid Myoclonia With Absences.

Cerulli Irelli E, Cocchi E, Ramantani G, Caraballo RH, Giuliano L, Yilmaz T, Morano A, Panagiotakaki E, Operto FF, Gonzalez Giraldez B, Silvennoinen K, Casciato S, Comajuan M, Balestrini S, Fortunato F, Coppola A, Di Gennaro G, Labate A, Sofia V, Kluger GJ, Kasteleijn-Nolst Trenité DGA, Gambardella A, Baykan B, Sisodiya SM, Arzimanoglou A, Striano P, Di Bonaventura C, EMA Study Group.

Neurology. 2022 05 03.98(18):e1865-e1876.

PMID: 35292555

FI: 12,258

Heterozygous and Homozygous Variants in SORL1 Gene in Alzheimer's Disease Patients: Clinical, Neuroimaging and Neuropathological Findings.

Alvarez-Mora MI, Blanco-Palmero VA, Quesada-Espinosa JF, Arteche-Lopez AR, Llamas-Velasco S, Palma Milla C, Lezana Rosales JM, Gomez-Manjon I, Hernandez-Lain A, Jimenez Almonacid J, Gil-Fournier B, Ramiro-León S, González-Sánchez M, Herrero-San Martín AO, Pérez-Martínez DA, Gómez-Tortosa E, Carro E, Bartolomé F, Gomez-Rodriguez MJ, Sanchez-Calvin MT, Villarejo-Galende A, Moreno-Garcia M.

Int J Mol Sci. 2022 Apr 11.23(8).

PMID: 35457051

FI: 6,208

Smoking is associated with age at disease onset in Parkinson's disease.

Rosas I, Morís G, Coto E, Blázquez-Estrada M, Suárez E, García-Fernández C, Martínez C, Herrera ID, Pérez-Oliveira S, Álvarez V, Menéndez-González M, Spain_PD consortium (Cici Feliz, Pedro García-Ruiz).

Parkinsonism Relat Disord. 2022 Apr.97:79-83.

PMID: 35364453

FI: 4,402

Impact of New Systemic Therapies in Overall Survival in Non-Metastatic Castration Resistant Prostate Cancer: Systematic Review and Meta-Analysis.

Rodriguez-Vida A, Rodríguez-Alonso A, Useros-Rodríguez E, Lopez-Campos F, Amor-Carro O, Arribas-Ruiz A, Martinez-Torres J, Roca-Pardiñas J, Quesada-García A, Muñoz-Del-Toro JR, Juárez-Soto Á.

Clin Genitourin Cancer. 2022 04.20(2):197.e1-197.e10.

PMID: 34920959

FI: 3,121

Efficacy and safety of adjunctive cenobamate: Post-hoc analysis of study C017 in patients grouped by mechanism of action of concomitant antiseizure medications.

Brandt C, Sánchez-Álvarez JC, Steinhoff BJ, Milanov I, Serratosa JM.

Seizure. 2022 Mar.96:86-93.

PMID: 35168142

FI: 3,414

Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis.

Sainz de la Maza S, Sabin Muñoz J, Pilo de la Fuente B, Thuissard I, Andreu-Vázquez C, Galán Sánchez-Seco V, Salgado-Cámara P, Costa-Frossard L, Monreal E, Ayuso-Peralta L, García-Vasco L, García-Domínguez JM, Martínez-Ginés ML, Muñoz Fernández C, Díaz-Díaz J, Oreja-Guevara C, Gómez-Moreno M, Martín H, Rubio-Flores L, Blasco MR, Villar-Guimerans LM, Aladro Y, Dimethyl Fumarate Study Group.

Mult Scler Relat Disord. 2022 Mar.59:103669.

PMID: 35150979

FI: 4,808

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

Jansen WJ, Janssen O, Tijms BM, et. al.

JAMA Neurol. 2022 03 01.79(3):228-243.

PMID: 35099509

FI: 29,907

On the reversibility of parkinsonian tremor. Brief review and hypothesis.

Garcia Ruiz PJ, Ruiz Lopez M, Feliz CE.

Neurologia (Engl Ed). 2022 Jan-Feb.37(1):74-76.

PMID: 35074192

FI: 5,486

Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group.

Santos García D, García Roca L, de Deus Fonticoba T, Cores Bartolomé C, Naya Ríos L, Canfield H, Paz González JM, Martínez Miró C, Jesús S, Aguilar M, Pastor P, Planellas L, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Puente V, Dotor García-Soto J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Blázquez Estrada M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues O, González Ardura J, Alonso Redondo R, Ordás C, López Díaz L LM, McAfee D, Martinez-Martin P, Mir P, COPPADIS Study Group.

J Parkinsons Dis. 2022.12(1):315-331.

PMID: 34602501

FI: 5,52